Biotechnology Innovation Organization
14 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Biotechnology Innovation Organization
Federal lobbying records
Bills it lobbied on8 of 118
S 1096 Preserve Access to Affordable Generics and Biosimilars Act8 reports · On the floor calendarS 527 Prescription Pricing for the People Act of 20258 reports · On the floor calendarS 1546 Patent Eligibility Restoration Act of 20256 reports · In committeeS 526 Pharmacy Benefit Manager Transparency Act of 20256 reports · In committeeS 1095 Stop STALLING Act6 reports · On the floor calendarHR 6166 Lowering Drug Costs for American Families Act4 reports · In committeeSB 598 Biosimilars4 reports · VetoedSB 212 Solid waste: pharmaceutical and sharps waste stewardship4 reports · Became lawEvery link on this map
The same connections as a table, with the reason each one is here.
| S 1096 | Bills it lobbied on | Biotechnology Innovation Organization named S 1096, “Preserve Access to Affordable Generics and Biosimilars Act”, in 8 lobbying reports. | 8 reports |
| S 527 | Bills it lobbied on | Biotechnology Innovation Organization named S 527, “Prescription Pricing for the People Act of 2025”, in 8 lobbying reports. | 8 reports |
| S 1546 | Bills it lobbied on | Biotechnology Innovation Organization named S 1546, “Patent Eligibility Restoration Act of 2025”, in 6 lobbying reports. | 6 reports |
| S 526 | Bills it lobbied on | Biotechnology Innovation Organization named S 526, “Pharmacy Benefit Manager Transparency Act of 2025”, in 6 lobbying reports. | 6 reports |
| S 1095 | Bills it lobbied on | Biotechnology Innovation Organization named S 1095, “Stop STALLING Act”, in 6 lobbying reports. | 6 reports |
| HR 6166 | Bills it lobbied on | Biotechnology Innovation Organization named HR 6166, “Lowering Drug Costs for American Families Act”, in 4 lobbying reports. | 4 reports |
| SB 598 | Bills it lobbied on | Biotechnology Innovation Organization named SB 598, “Biosimilars”, in 4 lobbying reports. | 4 reports |
| SB 212 | Bills it lobbied on | Biotechnology Innovation Organization named SB 212, “Solid waste: pharmaceutical and sharps waste stewardship”, in 4 lobbying reports. | 4 reports |
| Thom Tillis | Lawmakers it funded or lobbied | Thom Tillis leads 1 bill Biotechnology Innovation Organization lobbied on. | Leads 1 of these bills |
| Amy Klobuchar | Lawmakers it funded or lobbied | Amy Klobuchar leads 2 bills Biotechnology Innovation Organization lobbied on. | Leads 2 of these bills |
| Charles Grassley | Lawmakers it funded or lobbied | Charles Grassley leads 2 bills Biotechnology Innovation Organization lobbied on. | Leads 2 of these bills |
| Frank Pallone | Lawmakers it funded or lobbied | Frank Pallone leads 1 bill Biotechnology Innovation Organization lobbied on. | Leads 1 of these bills |
| Hannah-Beth Jackson | Lawmakers it funded or lobbied | Hannah-Beth Jackson leads 1 bill Biotechnology Innovation Organization lobbied on. | Leads 1 of these bills |
| Jerry Hill | Lawmakers it funded or lobbied | Jerry Hill leads 1 bill Biotechnology Innovation Organization lobbied on. | Leads 1 of these bills |